Ninety One UK Ltd Decreases Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Ninety One UK Ltd reduced its stake in UnitedHealth Group by 33.6% in Q2, owning 105,070 shares valued at approximately $32.8 million after selling 53,126 shares during the period.
• Several institutional investors, including Vanguard Group Inc. and Wellington Management Group LLP, increased their holdings in UnitedHealth Group, showcasing continued interest among large investors.
• UnitedHealth Group's Q2 earnings report revealed an EPS of $4.08, missing estimates, with the company forecasting an EPS of 16.000 for FY 2025, while maintaining a dividend yield of 2.6%.

Ninety One UK Ltd trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 33.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 105,070 shares of the healthcare conglomerate's stock after selling 53,126 shares during the period. Ninety One UK Ltd's holdings in UnitedHealth Group were worth $32,779,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of UNH. Vanguard Group Inc. boosted its holdings in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares during the period. Wellington Management Group LLP boosted its stake in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of UnitedHealth Group by 2.5% in the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock valued at $4,257,131,000 after purchasing an additional 196,696 shares during the period. Nuveen LLC purchased a new position in UnitedHealth Group in the 1st quarter valued at about $3,846,764,000. Finally, Charles Schwab Investment Management Inc. boosted its position in UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock valued at $3,702,736,000 after buying an additional 847,054 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Truist Financial increased their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a report on Tuesday, September 9th. Piper Sandler reduced their target price on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Robert W. Baird reiterated an "underperform" rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Bank of America increased their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research note on Monday, August 18th. Finally, Barclays increased their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $345.11 on Wednesday. The stock has a market capitalization of $312.56 billion, a P/E ratio of 14.95, a P/E/G ratio of 2.25 and a beta of 0.45. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm's 50-day moving average price is $303.65 and its two-hundred day moving average price is $357.64.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.